Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers
Condition(s):Tobacco Use Disorder; SmokingLast Updated:April 4, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Tobacco Use Disorder; SmokingLast Updated:April 4, 2017Completed
Condition(s):Gastroduodenal UlcerationLast Updated:June 7, 2022Completed
Condition(s):Lung Cancer Non-small Cell Stage IVLast Updated:July 23, 2020Unknown status
Condition(s):Thromboembolism; BleedingLast Updated:August 5, 2014Completed
Condition(s):Drug Action IncreasedLast Updated:July 27, 2023Completed
Condition(s):Blood Loss, Surgical; Intraoperative Complications; Re-operation Rates in Patients With Aspirin TreatmentLast Updated:March 19, 2024Withdrawn
Condition(s):Thrombocytopenia; Myocardial InfarctionLast Updated:August 1, 2012Terminated
Condition(s):Aspirin HypersensitivityLast Updated:July 28, 2016Completed
Condition(s):Coronary AtherosclerosisLast Updated:January 19, 2022Unknown status
Condition(s):Coronary Heart Disease; Angina Pectoris; AtherosclerosisLast Updated:March 23, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.